CHICAGO, Aug. 28, 2024 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR), the leading international organization dedicated to finding a cure for sarcoidosis and improving care for sarcoidosis patients, is pleased to announce the appointment of fourteen new members to serve the organization's Scientific Advisory Board (SAB). This brings the current SAB membership to 25 members .
The FSR SAB consists of world-renowned researchers, clinicians, and health industry leaders representing diverse professional disciplines with experience in advancing research, clinical trials, and the scientific understanding of sarcoidosis. The FSR SAB provides guidance to the FSR Board of Directors and FSR leadership on scientific priorities and strategies, ensures FSR's educational material reflects the most up-to-date scientific knowledge, and applies experience and rigor to ensure FSR's grant funding is awarded towards the most innovative and scientifically promising research efforts. "We are thrilled and honored to welcome these fourteen dedicated sarcoidosis experts to the SAB," said Dr.
Elliot Crouser MD, Physician and Professor at the Ohio State University and SAB Chair. "We look forward to advancing the mission of FSR, and the broad expertise reflected in this expanded advisory board should prove to be quite impactful." This panel reflects the most diverse set of expertise in FSR's 25-year history.
By bringing together experts in pulmonology, genetics, rheumatology, neurology.